Literature DB >> 30365229

Gram-scale production of carrier-free fluorescent berberine microrods for selective liver cancer therapy.

Xiao Zheng1, Fan Zhang1, Dan Shao1,2, Zhanqiang Zhang1, Lianzhi Cui1,3, Jing Zhang1, Jianati Dawulieti1, Zhaojie Meng1, Ming Zhang1, Li Chen1,4.   

Abstract

Berberine, a widely used isoquinoline alkaloid in traditional Chinese medicine, has been proved to be a potential candidate in liver cancer therapy. However, the low therapeutic dose in the tumor target which is due to the poor solubility and oral bioavailability has limited its clinical application. In this study, fluorescent self-carried Berberine microrods (Ber-MRs) were prepared in gram-scale through a facile and cheap antisolvent precipitation method. Ber-MRs exhibited good optical properties, pH-responsive drug release behavior and selective and safe antitumor performance in vitro and in vivo without obvious toxicity. These findings have demonstrated that Ber-MRs are promising for efficient and safe liver cancer therapy.
© 2018 BioFactors, 44(5):496-502, 2018. © 2018 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  berberine; carrier-free; gram-scale; micro-rods

Mesh:

Substances:

Year:  2018        PMID: 30365229     DOI: 10.1002/biof.1450

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  5 in total

Review 1.  Nanodelivery of phytobioactive compounds for treating aging-associated disorders.

Authors:  Oleh Lushchak; Olha Strilbytska; Alexander Koliada; Alina Zayachkivska; Nadia Burdyliuk; Ihor Yurkevych; Kenneth B Storey; Alexander Vaiserman
Journal:  Geroscience       Date:  2019-11-04       Impact factor: 7.713

Review 2.  Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer.

Authors:  Yi Zhu; Na Xie; Yilu Chai; Yisen Nie; Ke Liu; Yufei Liu; Yang Yang; Jinsong Su; Chuantao Zhang
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

3.  Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer.

Authors:  Shuting Zuo; Jing Wang; Xianquan An; Zhenyu Wang; Xiao Zheng; Yan Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-08-12

4.  Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.

Authors:  Siqi Huang; Zheyu Zhang; Wenqun Li; Fanhua Kong; Pengji Yi; Jianhua Huang; Dan Mao; Weijun Peng; Sifang Zhang
Journal:  Drug Des Devel Ther       Date:  2020-07-14       Impact factor: 4.162

Review 5.  Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization.

Authors:  Solomon Habtemariam
Journal:  Molecules       Date:  2020-03-20       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.